申请人:Iinuma Munekazu
公开号:US20150087846A1
公开(公告)日:2015-03-26
A lifestyle disease improving drug that enhances PPARα, δ and γ agonist activities that includes a compound having the lactone structure in accordance with the chemical formula 6-alkyl-5,6-dihydro-2H-pyran-2-one, the alkyl containing 4, 5, or 6 carbons, and a method for synthesizing the compound. The method includes adding, stepwise, a butyllithium-hexane solution to a diisopropylamine-tetrahydrofuran solution, and then a 6-alkyltetrahydro-2H-pyran-2-one-tetrahydrofuran solution, wherein the alkyl contains 4, 5, or 6 carbons, adding a phenylselenyl choloride-tetrahydrofuran solution to produce a reaction mixture with a phenylselenide, extracting and purifying the phenylselenide, preparing a phenylselenide-tetrahydrofuran solution with the purified phenylselenide, and adding sodium bicarbonate and an aqueous hydrogen peroxide solution to the phenylselenide-tetrahydrofuran solution to produce a reaction mixture including the compound.
这是一种改善生活方式疾病的药物,它增强了PPARα、δ和γ激动剂活性,包括符合化学式6-烷基-5,6-二氢吡喃-2-酮的内酯结构化合物,其中烷基含有4、5或6个碳,并提供一种合成该化合物的方法。该方法包括逐步向二异丙基胺-四氢呋喃溶液中加入丁基锂-己烷溶液,然后加入6-烷基四氢-2H-吡喃-2-酮-四氢呋喃溶液,其中烷基含有4、5或6个碳,加入苯基硒酰氯-四氢呋喃溶液以产生含苯基硒酸盐的反应混合物,提取和纯化苯基硒酸盐,制备含纯化苯基硒酸盐的苯基硒酸盐-四氢呋喃溶液,并向该溶液中加入碳酸氢钠和水合氧化氢溶液,以产生包括该化合物的反应混合物。